Balanced Epigenetic Regulation of MHC Class I Expression in Tumor Cells by the Histone Ubiquitin Modifiers BAP1 and PCGF1
Wijdeven, Ruud H, Luk, Sietse J, Schoufour, Tom A W, van der Zanden, Sabina Y, Cabezuelo, Marta, Heemskerk, Mirjam H M, Neefjes, Jacques
Published in The Journal of immunology (1950) (01.02.2024)
Published in The Journal of immunology (1950) (01.02.2024)
Get full text
Journal Article
Thermal‐exchange HLA‐E multimers reveal specificity in HLA‐E and NKG2A/CD94 complex interactions
Ruibal, Paula, Derksen, Ian, Wolfswinkel, Marjolein, Voogd, Linda, Franken, Kees L. M. C., El Hebieshy, Angela F., Hall, Thorbald, Schoufour, Tom A. W., Wijdeven, Ruud H., Ottenhoff, Tom H. M., Scheeren, Ferenc A., Joosten, Simone A.
Published in Immunology (01.03.2023)
Published in Immunology (01.03.2023)
Get full text
Journal Article
CRISPR-Cas9 screening reveals a distinct class of MHC-I binders with precise HLA-peptide recognition
Schoufour, Tom A.W., van der Plas - van Duijn, Anneloes, Derksen, Ian, Melgers, Marije, van Veenendaal, Jacqueline M.F., Lensen, Claire, Heemskerk, Mirjam H.M., Neefjes, Jacques, Wijdeven, Ruud H.M., Scheeren, Ferenc A.
Published in iScience (21.06.2024)
Published in iScience (21.06.2024)
Get full text
Journal Article
The MHC-E peptide ligands for checkpoint CD94/NKG2A are governed by inflammatory signals, whereas LILRB1/2 receptors are peptide indifferent
Middelburg, Jim, Ghaffari, Soroush, Schoufour, Tom A.W., Sluijter, Marjolein, Schaap, Gaby, Göynük, Büsra, Sala, Benedetta M., Al-Tamimi, Lejla, Scheeren, Ferenc, Franken, Kees L.M.C., Akkermans, Jimmy J.L.L., Cabukusta, Birol, Joosten, Simone A., Derksen, Ian, Neefjes, Jacques, van der Burg, Sjoerd H., Achour, Adnane, Wijdeven, Ruud H.M., Weidanz, Jon, van Hall, Thorbald
Published in Cell reports (Cambridge) (26.12.2023)
Published in Cell reports (Cambridge) (26.12.2023)
Get full text
Journal Article